COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,552 Articles (22,881 medRxiv, 8,671 bioRxiv)

Most recent first Previous |  Page 2352: Articles 23511-23520  | Next

Hesitant or not? A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, J. V., Ratzan, S., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S., El-Mohandes, A.
10.1101/2020.08.23.20180307 — Posted: 2020-08-25
Suitability of Google Trends ™ for digital surveillance during ongoing COVID-19 epidemic: a case study from India
Satpathy, P. D., Kumar, S., Prasad, P.
10.1101/2020.08.24.20176321 — Posted: 2020-08-25
Wastewater sample site selection to estimate geographically-resolved community prevalence of COVID-19: A research protocol
Yeager, R. A., Holm, R. H., Saurabh, K., Fuqua, J. L., Talley, D., Bhatnagar, A., Smith, T. R.
10.1101/2020.08.23.20180224 — Posted: 2020-08-25
IMPACT OF COVID-19 PANDEMIC LED LOCKDOWN ON THE LIFESTYLE OF ADOLESCENTS AND YOUNG ADULTS
ROY, S., TIWARI, S., KANCHAN, S., BAJPAI, P.
10.1101/2020.08.22.20180000 — Posted: 2020-08-25
Mask Wearing and Control of SARS-CoV-2 Transmission in the United States
Rader, B., White, L. F., Burns, M. R., Chen, J., Brilliant, J., Cohen, J., Shaman, J., Brilliant, L., Hawkins, J. B., Scarpino, S. V., Astley, C., Brownstein, J. S.
10.1101/2020.08.23.20078964 — Posted: 2020-08-25
The Futures of the Pandemic in the USA : A Timed Intervention Model
Hachtel, G. D.
10.1101/2020.08.23.20180174 — Posted: 2020-08-25
Epidemiologically most successful SARS-CoV-2 variant: concurrent mutations in RNA-dependent RNA polymerase and spike protein
Ilmjärv, S., Abdul, F., Acosta-Gutierrez, S., Estarellas, C., Galdadas, I., Casimir, M., Alessandrini, M., Gervasio, F. L., Krause, K.-H.
10.1101/2020.08.23.20180281 — Posted: 2020-08-25
COVID-19: Estimation of the Actual Onset of Local Epidemic Cycles, Determination of Total Number of Infective, and Duration of the Incubation Period
De Carvalho, R. A., De Carvalho, E. A.
10.1101/2020.08.23.20180356 — Posted: 2020-08-25 Discussion: Onsite
Impact of nonpharmaceutical governmental strategies for prevention and control of COVID-19 in Sao Paulo State, Brazil.
Fortaleza, C. R., Vilches, T. N., Berg de Almeida, G., Ferreira, C. P., Grotto, R. M. T., Guimaraes, R. B., de Souza, L. d. R., Fortaleza, C. M. C. B.
10.1101/2020.08.23.20180273 — Posted: 2020-08-25
The analysis of the long-term impact of SARS-CoV-2 on the cellular immune system in individuals recovering from COVID-19 reveals a profound NKT cell impairment
liu, j., Yang, X., Wang, H., Li, Z., Deng, H., jing, L., Xiong, S., He, J., Guo, C., Wang, W., Zelinskyy, G., Trilling, M., Dittmer, U., Lu, M., Sutter, K., Senff, T., Menne, C., Timm, J., Zhang, Y., Deng, F., Feng, X., Lu, Y., Wu, J., Yang, D., Wang, B., Zheng, X.
10.1101/2020.08.21.20179358 — Posted: 2020-08-25 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).